39 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
at Incannex Australia from August 2022 to November 2023. He is a seasoned expert in strategic regulatory affairs, boasting over 38 years of extensive … is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
strategic regulatory affairs expert with over 38 years of U.S. and international regulatory experience, including more than 20 years with Pfizer Inc … . and more than 10 years with Novo Nordisk A/S. He is an expert on FDA and EMA matters, U.S. pharmaceutical advertising practices and regulatory aspects
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
of Incannex Australia from August 2022 to November 2023. Mr. Clark is a senior-level strategic regulatory affairs expert with over 38 years of U.S … . and international regulatory experience, including more than 20 years with Pfizer Inc. and more than 10 years with Novo Nordisk A/S. He is an expert
8-K
EX-2.1
IXHL
Incannex Healthcare Limited
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
, from time to time.
Independent Expert means a person to be appointed by Incannex to prepare the Independent Expert’s Report.
Scheme Implementation … Deed
DMS:YXG: 5412447
Legal/83374955_3
Page 4
Independent Expert’s Report means the independent expert’s report prepared by the Independent Expert
8-K
EX-10.1
IXHL
Incannex Healthcare Limited
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
) information or records given or reports made to the Enterprise by an independent certified public accountant, an appraiser, investment banker or other expert
8-K
EX-3.2
26n3sykx5 mcc
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
golz951 gb47fx4
8 Nov 23
Results of Scheme Meetings
6:07am
6-K
EX-99.1
3y7k6cde
5 Oct 23
Court Approves Convening of Meetings to Consider Proposed Schemes
7:47am
6-K
EX-99.2
m64e5
5 Oct 23
Court Approves Convening of Meetings to Consider Proposed Schemes
7:47am
6-K
EX-99.1
unmcr rtf2cpb7xc
1 Sep 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
n3gif36
10 Jul 23
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
8:43am
6-K
EX-99.1
dchtg uuzz3v
30 May 23
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
4e4tn lmnff0sa
18 May 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
5z5qe66 m9hy
28 Nov 22
Incannex Engages Eurofins to Manufacture ReneCann Therapeutic Topical Application for Immune Disordered Skin Diseases
8:19pm
6-K
EX-99.1
bib2o1
25 Nov 22
Incannex Engages Eurofins to Manufacture Novel Addiction Treatments CannQuit-N and CannQuit-O
6:08am
20-F
m42eu8h9 8i
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
or9c3pp3uz3ms
21 Oct 22
Report of Foreign Private Issuer
6:08am
6-K
EX-99.1
u0g lyhyqf
19 Sep 22
Report of Foreign Private Issuer
9:38pm